{"id":53808,"date":"2025-11-30T12:59:10","date_gmt":"2025-11-30T12:59:10","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/53808\/"},"modified":"2025-11-30T12:59:10","modified_gmt":"2025-11-30T12:59:10","slug":"uus-ja-ullatav-korvaltoime-ozempicu-kasutajatel-voib-tekkida-ootamatu-vaevus","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/53808\/","title":{"rendered":"Uus ja \u00fcllatav k\u00f5rvaltoime? Ozempicu kasutajatel v\u00f5ib tekkida ootamatu vaevus"},"content":{"rendered":"<p>Ozempicu ja teiste GLP-1 t\u00fc\u00fcpi ravimite populaarsus kasvab endiselt \u2013 need aitavad langetada veresuhkrut, toetada kehakaalu kontrolli ja pidurdada isu. Kuid aina enam koguneb infot ka v\u00f5imalike k\u00f5rvaln\u00e4htude kohta. Lisaks iiveldusele, seedeh\u00e4iretele ja v\u00e4simusele osutavad teadlased n\u00fc\u00fcd veel \u00fchele n\u00e4htusele, mis v\u00f5ib panna \u00fcmbritsevad k\u00fcsima, kas oled k\u00fclmetunud.<\/p>\n","protected":false},"excerpt":{"rendered":"Ozempicu ja teiste GLP-1 t\u00fc\u00fcpi ravimite populaarsus kasvab endiselt \u2013 need aitavad langetada veresuhkrut, toetada kehakaalu kontrolli ja&hellip;\n","protected":false},"author":2,"featured_media":53809,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80],"tags":[3695,26,27,37,33,35,34,36,31,32,7928,21,1216,27318,28,29,95,27319,19,3401,25,23,24,22,6847,20,30,92,93,94],"class_list":{"0":"post-53808","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-maailm","8":"tag-alzheimeri-tobi","9":"tag-breaking-news","10":"tag-breakingnews","11":"tag-ee","12":"tag-eesti","13":"tag-eesti-keel","14":"tag-estonia","15":"tag-estonian","16":"tag-featured-news","17":"tag-featurednews","18":"tag-glp-1-ravimid","19":"tag-headlines","20":"tag-kliinilised-uuringud","21":"tag-krooniline-koha","22":"tag-latest-news","23":"tag-latestnews","24":"tag-maailm","25":"tag-maksahaigused","26":"tag-news","27":"tag-ozempic","28":"tag-populaarseimad-lood","29":"tag-top-stories","30":"tag-topstories","31":"tag-uldised-uudised","32":"tag-uneapnoe","33":"tag-uudised","34":"tag-viimased-uudised","35":"tag-world","36":"tag-world-news","37":"tag-worldnews"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/115638774445337134","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/53808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=53808"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/53808\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/53809"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=53808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=53808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=53808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}